28515354|t|Clinical application and outcomes of sentinel node navigation surgery in patients with early gastric cancer
28515354|a|Sentinel node navigation surgery (SNNS) has been recognized as a minimally invasive tool for individualized lymphadenectomy in patients with early gastric cancer (EGC). The aim of this study was to compare clinicopathological factors, adverse events, and clinical outcomes between sentinel node mapping (SNM) and SN dissection (SND) groups and assess the clinical utility of SNNS in patients with EGC. The clinical data of 157 patients with EGC, diagnosed as clinical T1N0M0 with tumors â‰¤ 40 mm, undergoing SNNS between March 2004 and April 2016 were retrospectively reviewed. Twenty-seven patients were excluded from the analysis. In the remaining 130 patients, 59 and 71 patients underwent standard lymphadenectomy for SNM and SND, respectively. The sentinel node detection rate in the SNM and SND groups was 98.3% (58/59) and 100% (71/71), respectively. Two (3.5%), 15 (25.9%), and 41 (70.7%) patients having sentinel nodes underwent total gastrectomy, proximal gastrectomy (PG), and distal gastrectomy (DG), respectively, in the SNM group. One (1.4%), 5 (7.0%), 10 (14.1%), 39 (54.9%), and 16 (22.5%) patients underwent PG, DG, segmental gastrectomy, local resection, and endoscopic submucosal dissection, respectively, in the SND group. There was no significant difference in postoperative complications between the SNM and SND groups (P = 0.781). Survival did not differ between the both groups (P = 0.856). The present results suggest that personalized surgery with SND provides technical safety and curability related with a favorable survival outcome in patients with EGC.
28515354	0	8	Clinical	T080	C0205210
28515354	9	20	application	T169	C4048755
28515354	25	33	outcomes	T169	C1274040
28515354	37	69	sentinel node navigation surgery	T061	C0543467
28515354	73	81	patients	T101	C0030705
28515354	87	107	early gastric cancer	T191	C0349530
28515354	108	140	Sentinel node navigation surgery	T061	C0543467
28515354	142	146	SNNS	T061	C0543467
28515354	201	215	individualized	T080	C1709510
28515354	216	231	lymphadenectomy	T061	C0024203
28515354	235	243	patients	T101	C0030705
28515354	249	269	early gastric cancer	T191	C0349530
28515354	271	274	EGC	T191	C0349530
28515354	293	298	study	T062	C2603343
28515354	306	313	compare	T052	C1707455
28515354	314	333	clinicopathological	T169	C1521733
28515354	334	341	factors	T169	C1521761
28515354	343	357	adverse events	T046	C0877248
28515354	363	371	clinical	T080	C0205210
28515354	372	380	outcomes	T169	C1274040
28515354	389	410	sentinel node mapping	T060	C1519247
28515354	412	415	SNM	T060	C1519247
28515354	421	434	SN dissection	T061	C0242382
28515354	436	439	SND	T061	C0242382
28515354	441	447	groups	T078	C0441833
28515354	463	471	clinical	T080	C0205210
28515354	472	479	utility	T169	C0457083
28515354	483	487	SNNS	T061	C0543467
28515354	491	499	patients	T101	C0030705
28515354	505	508	EGC	T191	C0349530
28515354	514	527	clinical data	T170	C1516606
28515354	535	543	patients	T101	C0030705
28515354	549	552	EGC	T191	C0349530
28515354	554	563	diagnosed	T033	C0011900
28515354	567	575	clinical	T080	C0205210
28515354	576	594	T1N0M0 with tumors	T191	C0027651
28515354	615	619	SNNS	T061	C0543467
28515354	659	674	retrospectively	T080	C1514923
28515354	675	683	reviewed	T080	C1709940
28515354	698	706	patients	T101	C0030705
28515354	712	720	excluded	T052	C2828389
28515354	730	738	analysis	T062	C0936012
28515354	761	769	patients	T101	C0030705
28515354	781	789	patients	T101	C0030705
28515354	809	824	lymphadenectomy	T061	C0024203
28515354	829	832	SNM	T060	C1519247
28515354	837	840	SND	T061	C0242382
28515354	860	873	sentinel node	T023	C1522495
28515354	874	883	detection	T061	C1511790
28515354	884	888	rate	T081	C1521828
28515354	896	899	SNM	T060	C1519247
28515354	904	907	SND	T061	C0242382
28515354	908	914	groups	T078	C0441833
28515354	1004	1012	patients	T101	C0030705
28515354	1020	1034	sentinel nodes	T023	C1522495
28515354	1051	1062	gastrectomy	T061	C0017118
28515354	1064	1084	proximal gastrectomy	T061	C0399713
28515354	1086	1088	PG	T061	C0399713
28515354	1095	1113	distal gastrectomy	T061	C0192440
28515354	1115	1117	DG	T061	C0192440
28515354	1141	1144	SNM	T060	C1519247
28515354	1145	1150	group	T078	C0441833
28515354	1213	1221	patients	T101	C0030705
28515354	1232	1234	PG	T061	C0399713
28515354	1236	1238	DG	T061	C0192440
28515354	1240	1249	segmental	T082	C0205122
28515354	1250	1261	gastrectomy	T061	C0017118
28515354	1263	1278	local resection	T061	C0278259
28515354	1284	1316	endoscopic submucosal dissection	T061	C1700929
28515354	1339	1342	SND	T061	C0242382
28515354	1343	1348	group	T078	C0441833
28515354	1389	1416	postoperative complications	T046	C0032787
28515354	1429	1432	SNM	T060	C1519247
28515354	1437	1440	SND	T061	C0242382
28515354	1441	1447	groups	T078	C0441833
28515354	1461	1469	Survival	T081	C0038954
28515354	1502	1508	groups	T078	C0441833
28515354	1534	1541	results	T169	C1274040
28515354	1555	1567	personalized	T080	C1709510
28515354	1568	1575	surgery	T061	C0543467
28515354	1581	1584	SND	T061	C0242382
28515354	1594	1610	technical safety	T068	C0036043
28515354	1651	1659	survival	T052	C0038952
28515354	1660	1667	outcome	T169	C1274040
28515354	1671	1679	patients	T101	C0030705
28515354	1685	1688	EGC	T191	C0349530